Validity of self-report in type 1 diabetic subjects for laser treatment of retinopathy

Ophthalmology

Volumn 120, Issue 12, 2013, Pages 2580-2586

  Grassi, Michael A ^a   Sun, Wanjie ^b   Gangaputra, Sapna ^c   Cleary, Patricia A ^b   Hubbard, Larry ^c   Lachin, John M ^b   Gao, Xiaoyu ^b   Kiss, Szilárd ^d   Barkmeier, Andrew J ^e   Almony, Arghavan ^f   Davis, Matthew ^c   Klein, Ronald ^c   Danis, Ronald P ^c  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e MAYO CLINIC   (United States)

^f University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ADULT; ARTICLE; COHORT ANALYSIS; DIABETIC RETINOPATHY; EYE PHOTOGRAPHY; FEMALE; FOCAL LASER PHOTOCOAGULATION; FUNDUS PHOTOGRAPHY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTERMETHOD COMPARISON; LASER COAGULATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PANRETINAL LASER PHOTOCOAGULATION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SELF REPORT; SENSITIVITY AND SPECIFICITY; STRUCTURED INTERVIEW; VALIDITY; CLINICAL TRIAL; COMPLICATION; LABORATORY DIAGNOSIS; PHOTOGRAPHY; STANDARDS; VALIDATION STUDY;

ADULT; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; LASER COAGULATION; MALE; PHOTOGRAPHY; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; SELF REPORT; SENSITIVITY AND SPECIFICITY;

EID: 84888016336     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2013.06.002     Document Type: Article

References (20)

1. Centers for Disease Control and Prevention National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011 2011 U.S. Department of Health and Human Services, Centers for Disease Control and Prevention Atlanta, GA Available at: http://www.cdc.gov/diabetes/pubs/pdf/ndfs-2011.pdf Accessed April 4, 2013
2. Eye Diseases Prevalence Research Group The prevalence of diabetic retinopathy among adults in the United States Arch Ophthalmol 122 2004 552 563
3. Diabetic Retinopathy Study Research Group Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS report number 8 Ophthalmology 88 1981 583 600
4. Early Treatment Diabetic Retinopathy Study Research Group Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1 Arch Ophthalmol 103 1985 1796 1806
5. Photocoagulation treatment of proliferative diabetic retinopathy: the second report of Diabetic Retinopathy Study findings Ophthalmology 85 1978 82 106
6. Diabetic Retinopathy Clinical Research Network, Writing Committee M.J. Elman, N.M. Bressler, and H. Qin Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema Ophthalmology 118 2011 609 614
7. Diabetic Retinopathy Clinical Research Network M.J. Elman, L.P. Aiello, and R.W. Beck Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema Ophthalmology 117 2010 1064 1077
8. Diabetic Retinopathy Clinical Research Network M.J. Elman, H. Qin, and L.P. Aiello Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results Ophthalmology 119 2012 2312 2318
9. J.E. Frampton Ranibizumab: in diabetic macular oedema Drugs 72 2012 509 523
10. Diabetes Control and Complications Trial Research Group The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus: the Diabetes Control and Complications Trial Arch Ophthalmol 113 1995 36 51
11. Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med 329 1993 977 986
12. Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort Diabetes Care 22 1999 99 111
13. M.A. Grassi, D.A. Mazzulla, and M.D. Knudtson Patient self-report of prior laser treatment reliably indicates presence of severe diabetic retinopathy Am J Ophthalmol 147 2009 501 504
14. L. Patty, C. Wu, and M. Torres Los Angeles Latino Eye Study Group. Validity of self-reported eye disease and treatment in a population-based study: the Los Angeles Latino Eye Study Ophthalmology 119 2012 1725 1730
15. J. Cohen A coefficient of agreement for nominal scales Educational and Psychological Measurement 20 1960 37 46
16. J.R. Landis, and G.G. Koch The measurement of observer agreement for categorical data Biometrics 33 1977 159 174
17. M.A. Grassi, A. Tikhomirov, and S. Ramalingam Genome-wide meta-analysis for severe diabetic retinopathy Hum Mol Genet 20 2011 2472 2481
18. R.E. Gilbert, C. Tsalamandris, and T.J. Allen Early nephropathy predicts vision-threatening retinal disease in patients with type I diabetes mellitus J Am Soc Nephrol 9 1998 85 89
19. A.H. Barnett, K. Dallinger, and P. Jennings Microalbuminuria and diabetic retinopathy [letter] Lancet 1 1985 53 54
20. Hixson L, Hepler BB, Kim MO. The White Population: 2010. 2010 Census Briefs. Washington, DC: U.S. Census Bureau; 2011. Publication no. C2010BR-05. Available at: http://www.census.gov/prod/cen2010/briefs/c2010br-05.pdf. Accessed April 4, 2013.